Search
EF-022
go.drugbank.com/drugs/DB17768InvestigationalEF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic and anti-angiogenic activities.
Synonyms: EF 022CSIC002
go.drugbank.com/drugs/DB18584ExperimentalIt is being investigated for the treatment of anterior ischemic optic neuropathy.
Streptolydigin
go.drugbank.com/drugs/DB04785ExperimentalIt is active against gram-postive bacteria except micrococci.
DT-DEC01
go.drugbank.com/drugs/DB19433ExperimentalDT-DEC01 is a novel Dystrophin Expressing Chimeric (DEC) cell therapy being investigated by Dystrogen Therapeutics Corporation.
Asoprisnil
go.drugbank.com/drugs/DB06680InvestigationalIt can be used to treat progesterone sensitive myomata.
Cabamiquine
go.drugbank.com/drugs/DB21477InvestigationalCabamiquine has a monoisotopic molecular weight of 462.24 Da. … Cabamiquine is under investigation in clinical trial NCT05974267 (Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium
Mequitazine
go.drugbank.com/drugs/DB01071InvestigationalIt competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. … It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.
Metrifonate
go.drugbank.com/drugs/DB11473ExperimentalVet approvedIt is a prodrug which is activated non-enzymatically into 2,2-dichlorovinyl dimethyl phosphate.
Moschus berezovskii musk sac resin
go.drugbank.com/drugs/DB14247InvestigationalIt is not an approved drug.
Swertia japonica whole flowering
go.drugbank.com/drugs/DB14268InvestigationalIt is not an approved drug.